Valerie Zeko emerged from 28 years of debilitating depression after participating in a groundbreaking trial at Stanford, ...

A study shows that a small, implanted device may provide substantial, long-lasting relief to people with the most severe treatment-resistant depression.

Cyclerion Strengthens Development of Closed-Loop Anesthetic Platform through Strategic Collaboration Agreement with Medsteer ...

Shares of Cyclerion Therapeutics climbed after the company entered an agreement to integrate Medsteer's technology into its lead program in development for treatment-resistant depression. The stock ...

Cyclerion Therapeutics entered an agreement to integrate Medsteer's technology into CYC-126, its lead program in development for treatment-resistant depression.